The Kansas City Area Life Sciences Institute released a new report Wednesday on what it will take to keep the region competitive in biotech over the next decade.
The report said that although the Kansas City region has made strides in the past decade toward becoming a major life sciences industry hub, it’s going to need a better educated workforce and $100 million or more in new venture capital.
The report noted a number of strengths in the life sciences, notably health care information technology with industry giant Cerner Corp., along with several startup companies and the Animal Health Corridor of research institutions and businesses extending from Kansas State University in Manhattan to the University of Missouri in Columbia.
With strong programs at the University of Kansas, University of Missouri, St. Luke’s Hospital and Children’s Mercy Hospital, research into cancer and neurological disorders holds great promise, the report said.
But the report also warned that the region has significant weaknesses that threaten future growth if not addressed.